Despite evidence for the efficacy of thrombolytic therapy in acute ischemic st roke, only 1 to 7%of patients receive this therapy. The authors sought to deter mine the reasons for exclusion from tissue plasminogen act...Despite evidence for the efficacy of thrombolytic therapy in acute ischemic st roke, only 1 to 7%of patients receive this therapy. The authors sought to deter mine the reasons for exclusion from tissue plasminogen activator (tPA) in an acu te setting and found avoidable causes in 18%of patients. Improvements in intrah ospital coordination would increase the number of patients who might benefit fro m tPA treatment at the authors’center.展开更多
文摘Despite evidence for the efficacy of thrombolytic therapy in acute ischemic st roke, only 1 to 7%of patients receive this therapy. The authors sought to deter mine the reasons for exclusion from tissue plasminogen activator (tPA) in an acu te setting and found avoidable causes in 18%of patients. Improvements in intrah ospital coordination would increase the number of patients who might benefit fro m tPA treatment at the authors’center.
